News
U.S. FDA Approves Gileads Antiviral Veklury (remdesivir) for Treatment...
Gilead Sciences, Inc. announced that the U.S. FDA has approved the antiviral drug Veklury® (remdesivir) for the treatment of patients with COVID-19 requiring hospitalization. As...
Drug Research
3P Biopharmaceuticals and SpyBiotech enter into a vaccine contract...
3P Biopharmaceuticals, a leading Contract Development and Manufacturing Organization (CDMO) specialized in process development and cGMP manufacturing of biologics, has signed a manufacturing agreement withSpyBiotech,...
News
Kamada Ltd, Signs a Supply Agreement with the Israeli...
The Israeli health authorities have signed a supply agreement for the investigational Covid-19 plasma-derived Immunoglobulin (IgG), to be supplied by Kamada Ltd., a biopharmaceutical company...
News
Covaxin: Bharat Biotech gets nod from DCGI panel for...
The phase 3 trials will be conducted in 19 sites across 10 states, including in cities such as Delhi, Mumbai, Patna and Lucknow and would...
News
Lonza Expands Its Capsule Manufacturing Capacity
Lonza announced a CHF85m (93m USD) investment in its Capsules and Health Ingredients (CHI) Division, a dosage form delivery partner to the biopharma and health...
News
Teknova Completes FDA Notification Process for COVID-19 Transport Media
Teknova, a leading manufacturer of cell culture media and supplements, protein purification buffers, and molecular biology reagents, has completed the United States FDA notification process...
News
Recipharm’s proprietary molecule Erdosteine has been positively tested as...
Recipharm is pleased to announce that the results of the study with Erdosteine as an add-on treatment for COVID-19 patients are now available.
The clinical study...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.